Enovis Corporation (ENOV)

NYSE: ENOV · Real-Time Price · USD

31.26

-0.76 (-2.37%)

At close: Oct 6, 2025, 4:00 PM EDT

31.60

+0.34 (1.09%)

After-hours: Oct 6, 2025, 7:33 PM EDT

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2013 - 2020
Period Ending	Jul '25 Jul 4, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2013 - 2020
United States Revenue	1.28B	1.25B	Log In	Log In	Log In	Upgrade
Foreign Locations Revenue	905.36M	861.95M	Log In	Log In	Log In	Upgrade
Revenue (Total)	2.19B	2.11B	Log In	Log In	Log In	Upgrade

Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2013 - 2020
Period Ending	Jul '25 Jul 4, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2013 - 2020
U.S. Bracing & Support Revenue	483.14M	469.32M	Log In	Log In	Log In	Upgrade
U.S. Other P&R Revenue	273.89M	270.74M	Log In	Log In	Log In	Upgrade
International P&R Revenue	367.32M	357.90M	Log In	Log In	Log In	Upgrade
Total Prevention & Recovery Revenue	1.12B	1.10B	Log In	Log In	Log In	Upgrade
U.S. Reconstructive Revenue	527.19M	505.62M	Log In	Log In	Log In	Upgrade
International Reconstructive Revenue	538.04M	504.05M	Log In	Log In	Log In	Upgrade
Total Reconstructive Revenue	1.07B	1.01B	Log In	Log In	Log In	Upgrade
Total Medical Technology Revenue	2.19B	2.11B	Log In	Log In	Log In	Upgrade
Revenue (Other)	-2.19B	-2.11B	Log In	Log In	Log In	Upgrade
Revenue (Total)	2.19B	2.11B	Log In	Log In	Log In	Upgrade

Adjusted EBITDA

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2013 - 2020
Period Ending	Jul '25 Jul 4, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2013 - 2020
Prevention & Recovery Adjusted EBITDA	168.17M	159.60M	Log In	Log In	Log In	Upgrade
Reconstructive Adjusted EBITDA	231.23M	216.92M	Log In	Log In	Log In	Upgrade
Operating Income (Other)	-1.16B	-1.15B	Log In	Log In	Log In	Upgrade
Operating Income (Total)	-760.05M	-775.72M	Log In	Log In	Log In	Upgrade

Capital Expenditures

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2013 - 2020
Period Ending	Jul '25 Jul 4, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2013 - 2020
Prevention & Recovery Capital Expenditures	-	34.00M	Log In	Log In	Log In	Upgrade
Reconstructive Capital Expenditures	-	146.71M	Log In	Log In	Log In	Upgrade
Total Medical Technology Capital Expenditures	-	180.71M	Log In	Log In	Log In	Upgrade

Key Performance Indicators

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	-7 - 0

Updated Aug 7, 2025. Data Source: Fiscal.ai.